Xspray Pharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gunnar Asplunds Alle 32, Solna, Stockhol...Phone Number
+46 87303700Website
www.xspraypharma.comRevenue
$7.9 MillionIndustry
About Xspray Pharma
Is Xspray Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Xspray Pharma launches new products
Click to see if Xspray Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Xspray Pharma
Xspray Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Xspray Pharma is spiking on competitors!
Earning: See what the market has to say on Xspray Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Xspray Pharma has new funding data
Check if Xspray Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Xspray Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Xspray Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xspray Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xspray Pharma.
Xspray Pharma Tech Stack
A closer look at the technologies used by Xspray Pharma
Most Recent Scoops
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xspray Pharma
Xspray Pharma AB specializes in developing innovative, patented amorphous product candidates that enhance existing protein kinase inhibitors (PKIs) for cancer treatment. Their unique technology allows them to market these improved drugs as soon as the original patents expire, providing a significant opportunity in a multi-billion dollar market. The... Read More